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ABSTRACT 
Deficiency of dystrophin, a cytoskeletal protein localized in the inner face of the 
plasma membrane in skeletal, cardiac and smooth muscle, results in Duchenne 
Muscular Dystrophy (DMD).  Through its interactions with extracellular matrix and 
plasma membrane proteins, dystrophin plays a role in contraction and signal 
transduction.   In DMD, gastrointestinal disorders such as gastric dilation and intestinal 
pseudo-obstruction resulting from altered motility have been reported.  The role of 
dystrophin in the regulation of contractile protein expression and smooth muscle 
function, per se, is not known.  Studies have suggested that inflammation contributes to 
the pathophysiology of DMD.  Exogenous H2S had been shown to exert beneficial 
cardiovascular and gastrointestinal functions, probably via exerting anti-inflammatory 
actions.  Aim.  To test the hypothesis that a lack of dystrophin causes a decrease in 
contractile protein expression and smooth muscle function and that treatment with H2S 
restores the effects of dystrophin deficiency.  Methods.  The role of dystrophin was 
examined using mice deficient in dystrophin alone (mdx) and mice deficient in 
dystrophin plus telomerase RNA (mdx/mTR), which exhibit increased disease severity. 
The effect of an orally-active, slow releasing H2S agent (SG1002) was tested in 
mdx/mTR mice (40 mg/kg body weight in chow/every 3 days starting from 3 weeks to 9 
months).  Contraction in response to acetylcholine (ACh) was measured in gastric 
muscle strips isolated from mdx, mdx/mTR and SG1002-treated mdx/mTR mice.  Age-
matched control mice were used for each group.  Contraction was also measured in 
muscle cells isolated from the stomach of control and mdx mice by scanning micrometry 
and expressed as the percent decrease in muscle cell length.  Expression of mRNA and 
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contractile proteins such as smoothelin, caldesmon, calponin and tropomyosin was 
measured by qRT- PCR and western blot.  Results.  Acetylcholine-induced contraction 
was reduced in muscle strips from mdx/mTR mice (18±4 mN/100 mg tissue) compared 
to age-matched 9-month old control mice (33±7 mN/100 mg tissue).  Treatment of 
mdx/mTR mice with SG1002 restored contraction to above normal levels (56 ± 8 
mN/100 mg tissue).  Contraction was also decreased in gastric muscle strips from mdx 
mice (24±5 mN/100 mg tissue) compared to age-matched 3- month old control mice 
(45±4 mN/100 mg tissue).  Both Ca2+-dependent initial contraction and Ca2+-
independent sustained contraction was also decreased in isolated gastric muscle cells 
from mdx mice compared to control mice.  Conclusion. The results support our 
hypothesis that dystrophin deficiency reduces smooth muscle contraction. Furthermore, 
treatment with H2S restores gastric smooth muscle function and contractile mRNA 
expression suggesting therapeutic potential of H2S in the treatment of motility disorders 
in DMD.  
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CHAPTER 1: INTRODUCTION 
 
Duchenne Muscular Dystrophy  
Duchenne Muscular Dystrophy (DMD) is an X-linked recessive disease that 
causes rapid skeletal muscle degeneration resulting from mutations in the dystrophin 
gene.  Dystrophin, a trans-sarcolemmal protein, plays an integral role in maintaining 
membrane integrity by protecting the cell from contraction-induced damage (Manning et 
al., 2016).  The dystrophin gene is the largest identified gene in humans and is 
comprised of 79 exons located on the short arm of chromosome Xp21 (Rodrigues et al, 
2016). The protein product of this gene is known to be around 400 kDa. In DMD, 65–
70% mutations are intragenic deletions, which most commonly occur in a region on the 
DMD gene spanning exons 45–53.  Duplications are found in in only 7% of patients, and 
point mutations or small deletions/insertions are observed in a small number of patients 
(Yiu, 2015).  DMD patients suffer from progressive loss of muscle function, leading to 
paralysis and death in the third decade of life (Sacco et al., 2010)  
Studies have shown that the failure of muscle stem cells, also known as satellite 
cells, to maintain the damage-repair cycle can also contribute to DMD progression. 
Myocyte regeneration is unable to keep up with constant myocyte damage leading to 
the replacement of myocytes with fibrotic and adipose tissue. It has been observed that 
patients with DMD exhibit skeletal muscle weakness by of 3 or 4 years of age. The 
deposition of fibrotic and adipose tissue may lead to pseudohypertophy of the calves. 
Children with DMD may have an unusual walk or waddling gait. By the age 13, children 
with DMD use a wheelchair. Cardiac and respiratory muscle damage eventually leads to 
serious, life threatening complications by the mid-twenties (Sacco et al., 2010). 
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The Role of Dystrophin 
Dystrophin is a large sarcolemmal protein located in a membrane-spanning 
protein complex. Dystrophin links the inner cytoskeleton to the extracellular matrix in 
skeletal, cardiac and smooth muscle. The majority of dystrophin is produced in skeletal, 
smooth and cardiac muscle but a small portion can also be found in nerve cells. 
Dystrophin has an N-terminal domain, a rod-shaped domain, cysteine rich domain and 
C-terminal domain. The amino terminal domain of dystrophin binds to F-actin, forming a 
link with internal cytoskeleton. The function of the cysteine rich and carboxyl terminal 
domains is to bind to the dystrophin-glycoprotein complex (DGC), a protein complex 
found at the plasma membrane of myofibers. In the presence of dystrophin, the DGC is 
able to maintain sarcolemmal integrity by serving as a signaling center and a buffer or 
shock absorber to reduce damage resulting from contraction (Rodrigues et al, 2016).  
In DMD the link between the cytoskeleton and the ECM is lost leaving the 
sarcolemma unable to endure the stress of normal muscle contractions (Lovering et al, 
2005). Additionally, the lack of dystrophin triggers membrane deregulation due to the 
disruption of the dystrophin glycoprotein complex (DGC), a membrane-spanning 
complex that plays a crucial role in signal transduction, including nitric oxide (NO) 
signaling.  Dystrophin is associated with the DCG and this interaction is thought to play 
a protective role during muscle contraction. Dystrophin is also needed for binding nitric 
oxide synthase (NOS), a part of the DCG protein complex, to the inner surface of the 
sarcolemma. In both DMD patients and in mdx mice, an animal model for DMD, it has 
been established that the sarcolemma is lacking NOS (Vannucchi et al, 2011). 
Furthermore, DMD has been associated with aberrant cell signaling, Ca2+ influx due to 
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increased membrane permeability, mitochondrial dysregulation leading to increased 
oxidative stress, inflammation, recurrent muscle ischemia and even fibrosis of smooth 
muscle (Mulè and Serio, 2002).  
 
Anatomy and Function of the Gastrointestinal Tract 
The main functions of the GI tract include absorbing nutrients after digestion, 
secreting enzymes to aid in digestion and absorption of nutrients.  The large surface 
area of the GI tract allows for optimal nutrient absorption.  The GI tract begins with the 
esophagus.  The chief functions of the esophagus are to propel the food bolus from the 
mouth to the stomach and also the lower esophageal sphincter will prevent reflux of 
gastric contents into the esophagus.  Once the bolus passes into the stomach, it is 
mixed with HCl for further breakdown.  The function of gastric contraction is to grind and 
mix food to produce chyme, a liquefied state of partially digested food. Chyme is then 
passed through the small intestine (duodenum) to the jejunum and then the ileum.  At 
this point most of the nutrient absorption has already occurred in the small intestine. 
The remaining chyme enters the colon ending in the rectum where it can be excreted 
from the anus as feces (Meerveld et al,  2017) 
The GI tract is divided into four layers interconnected by connective tissue, 
neural and vascular elements.  Facing the intestinal lumen is the first and innermost 
layer known as the Mucosa.  This is where the majority of absorption occurs and it is 
comprised of the innermost single layer epithelium, a middle lamina propria comprised 
of connective tissue and lymph nodes, and an outer muscularis mucosa.  The second 
layer is the submucosa, which contains lymphatics, inflammatory cells, autonomic nerve 
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fibers and ganglion cell.  The next layer is the muscularis propria, which functions to 
produce peristaltic waves that propel food through the GI tract.  The outer most layer is 
the known as the serosa and serves as a protective layer by forming a natural barrier 
from the spread of inflammation (Roa and Wang, 2010).  
 
Gastric Motility 
The major functions of the stomach include grinding and mixing ingested food 
with secretions to produce chyme, which can be passed into the small intestine.  The 
stomach can be diving into 3 major regions: the fundus, corpus and antrum (Cooke, 
1975).  The fundus is the most proximal portion of the stomach and is responsible for 
the basal tone present in the stomach.  Upon ingestion of food, the fundus will relax so 
that food may enter the GI tract.  This drop in gastric pressure immediately after eating 
is known as receptive relaxation.  Receptive relaxation requires vagal input, vago-vagal 
reflexes, and signals from the enteric nervous system (ENS) (Barrett, 2014).  The 
fundus also displays sustained low frequency, tonic contractions which are responsible 
to gastric emptying (Cooke, 1975). 
The antrum is located in the distal portion of the stomach and displays phasic 
contractions and strong peristaltic waves, which function largely to grind up the ingested 
meal by generating a pressure gradient from the stomach to small intestine.  In humans, 
these synchronized waves occur three times every 60 seconds. Interstitial cells of Cajal 
(ICC) play an important role in the generation of slow waves that determines these 3 
cycles per minute synchronized wave activity.  Lastly, the pylorus functions as a 
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sphincter that controls the movement of partially digested food into the small intestine 
(Barrett, 2014). 
 ENS and CNS regulation in addition to a complex network of hormones, 
autocrine/paracrine agents, and other local chemical signals work together to maintain 
proper gastric motility.  The stomach is innervated with both intrinsic and extrinsic neural 
inputs.  The enteric nervous system (ENS) serves as intrinsic control and is required for 
gastric motility.  The parasympathetic and sympathetic control serves as the extrinsic 
neural input, parasympathetic being more prominent.  Sympathetic innervation, which 
occurs at a much lesser degree, mostly functions to decrease gastric motility.  The 
control of gut motility requires interaction of regulatory systems at all levels including 
CNS, ENS, interstitial cells of Cajal (ICC) and smooth muscle cells (Manning et al., 
2016).  
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Figure 1.  This figure provides a schematic of the stomach, specifically 
displaying the location of phasic contraction and tonic contraction (Barrett, 2014). 
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GI Motility in mdx Mice 
Along with many skeletal muscle complications, many GI related symptoms have 
also been observed in DMD.  In patients, it has been observed that the absence of 
dystrophin can lead to GI abnormalities such as nausea, vomiting, delayed gastric 
emptying, hypo-motility, chronic constipation and even pseudo-obstruction (Manning et 
al., 2016).  When looking at mdx mice, diminished GI NO production/function has been 
reported.  NO is produced by neurons and smooth muscle cells in the mammalian 
stomach and is thought to play a major role gastrointestinal relaxations (Vannucchi et 
al., 2011). Consequently, significant alterations of the relaxation in the gastric fundus 
were observed in mdx mice when compared to WT.  Furthermore, the mdx gastric strips 
develop a major spontaneous tone while the WT mouse’s production of sufficient NO in 
the stomach restricts the level of spontaneous tone (Mulè et al., 2002). 
It has also been indicated that while the length of the intestine in both mdx and 
WT mice was very similar, a delay in intestinal transit time and decreased fecal output 
was observed in the mdx mouse (Mulè et al., 2010), suggesting there are significant 
alterations in mdx mice intestines in in vivo conditions.  Although, the gastric emptying 
of a non-nutrient meal consisting carboxymethyl cellulose/phenol red was not 
significantly different in control and mdx mice (Mulè et al., 2010), in DMD patients 
gastric emptying time was significantly delayed when compared to controls (Borrelli et 
al., 2005).  However, the mechanisms behind the delayed gastric empting are not 
known.  Specifically, how smooth muscle contractile proteins are affected and what role 
they are playing in dystrophin deficient smooth muscle is not known.  The decrease in 
electrical field stimulation (EFS)-induced relaxation in carbachol-precontracted fundus 
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muscle strips from mdx mice compared to normal mice was attributed to the impaired 
nitrergic neurotransmission (Baccari et al., 2010).  In addition, the full-length isoform of 
dystrophin is also expressed in ICC suggesting a dysfunctional ICC and slow wave 
activity (Vannucchi et al., 2004). 
 
Gastric Smooth Muscle 
Smooth muscle makes up the walls of hollow organs and tracts such as the 
arteries and veins of the circulatory system, the respiratory, urinary, GI and reproductive 
systems. Smooth muscle is differentiated from skeletal muscle, in part, due to the lack 
of striations in smooth muscle.  Smooth muscles cells are spindle shaped and 
mononucleated. Smooth muscle, unlike skeletal muscle, is not organized into 
sarcomeres.  The majority of the smooth muscle cells are comprised of dense bodies, 
homologous to the Z-lines present in striated muscle that attach to the plasma 
membrane, and contractile filaments (Gash and Varacallo, 2018). 
 
The Contractile Apparatus in Smooth Muscle 
The principal contractile apparatus in smooth muscle is comprised of thin 
filaments, thick filaments and intermediate filaments.  Intermediate filaments provide a 
linkage between cytoplasmic dense bodies and dense bands on the plasma membrane. 
Thin filaments consist of ~42 kDa protein actin, which exists in vivo as filamentous actin 
(F-actin). Thin filament associated proteins such as smoothelin, tropomyosin, 
caldesmon and calponin also play a role in the regulation of contraction.  Thick filaments 
are made of myosin molecules, hexamers comprising of a pair of myosin heavy chains 
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and two pairs of myosin light chains (MLCs).  Each of the heavy chains are 
asymmetrical, containing a globular head at the N-terminus, and form an α-helical core 
or tail by coiling around each other.  The globular head on the myosin filament is where 
the ATP binding site, actin binding site and intrinsic ATPase activity is located.  The 
interaction of actin with the myosin head and following hydrolysis of ATP is the 
fundamental reaction whereby cross bridge cycling and contraction occur generating 
force as a result of the sliding of the thin and thick filaments (Makhlouf and Murthy, 
2015). 
 
Regulation of Smooth Muscle Contraction by Thin-Filament Associated Proteins 
Thin filament associated proteins such as tropomyosin, calponin, caldesmon and 
smoothelin also play an important role in modulation of smooth muscle contraction by 
regulating actomyosin interaction (Lovering et al., 2005). 
Caldesmon: The Caldesmon gene is located on chromosome 7 and is 
comprised of at least 15 exons (Huber et al., 1997). Caldesmon is a protein that can be 
found as two isoforms: the smooth muscle specific h-caldesmon (heavy molecular 
weight) and the non-smooth muscle specific lower molecular weight l-caldesmon. H-
caldesmon consists of three main domains. The C-terminus contains two actin-binding 
sites, which block actin-myosin binding and disrupt actomyosin ATPase activity. It also 
has a calmodulin (CaM) binding site. The myosin binding N-terminus can also weakly 
bind to actin, tropomyosin and CaM (Eves, 2006). Lastly, h-Caldesmon contains a 
spacer region, giving it a larger molecular weight than it’s isoform, which is not known to 
strongly bind to actin or myosin. The main function of caldesmon is to tether the actin 
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thin filaments to myosin thick filaments. Upon smooth muscle stimulation, caldesmon is 
removed from the actin biding sites and phosphorylated myosin heads are able to bind 
to stimulate contraction. (Wang, 2001) 
Tropomyosin: Tropomyosin is a coiled-coil spanning seven-actin monomers. It 
exists as a heterodimer and is mostly made of α -helixes. Only two isoforms appear to 
be specific to smooth muscle—one from the β Tm gene and the other from the α Tm 
gene. The N-terminus of tropomyosin must be phosphorylated in order for it to have a 
good binding affinity to actin. As previously discussed, caldesmon inhibits actomyosin 
ATPase activity and motility. Studies have shown this effect of caldesmon is potentiated 
in the presence of tropomyosin-actin complex. In the absence of tropomyosin, 
caldesmon has weaker inhibitory effects on smooth muscle contraction (Marston, 2008). 
However, the exact mechanism of interaction between tropomyosin and caldesmon is 
not known (Marston and El-Mezgueldi, 2008). 
Calponin: Calponin is another smooth muscle specific thin filament associated 
contractile protein and exists as three isoforms; smooth muscle specific basic h1-
calponin, neutral h2-calponin found primarily in cardiac muscle, and an acidic variant 
which is not tissue-specific.  It is able to bind actin, Ca2+/calmodulin complex and 
tropomyosin.  Like many of the previously discussed proteins, calponin works to inhibit 
the actomyosin ATPase.  Protein kinase C (PKC) or CaM kinase II mediated 
phosphorylation inhibits these effects of calponin. In response to contractile stimuli such 
as Ca2+, calponin gets phosphorylated which allows for cross bridge cycling. Upon 
dephosphoraylation, calponin can reactivate and portray its inhibitory effects on smooth 
muscle contraction (Winder, 1993).  
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Smoothelin: Smoothelin A and B are both generated from the same gene 
located on chromosome 22. Smoothelin A is visceral smooth muscle specific and 
smoothelin B is vascular smooth muscle specific. Smoothelin is an actin binding protein 
that participates in smooth muscle contraction. The exact mechanism of action is 
unknown although studies have shown smoothelin knockout mice exhibited decreased 
contraction in response to contractile agonists. Another study was conducted to 
examine the effect of a smoothelin A/B knockout on intestinal smooth muscle in mice. 
The results demonstrated less intestinal flexibility and increased intestinal fragility. 
Circular and longitudinal muscle in the intestine of smoothelin KO mice showed 
hypertrophy. Additionally, there was a decrease in intestinal muscle contraction in the 
absence of smoothelin when compared to the wild type mice (Niessen et al, 2005) 
 
Signaling Mechanisms in Smooth Muscle Contraction 
Additionally, the excitation-contraction coupling mechanism in smooth muscle 
differs from skeletal muscle as well, including the mechanism that allows Ca2+ to enter 
the cell. The 3 mechanisms that increase intracellular concentration are voltage-gated 
Ca2+channels activated by membrane depolarization; the second method is hormones 
or neurotransmitters binding to and opening ligand-gated channels on the cell 
membrane allowing Ca2+influx and finally, hormones and neurotransmitters can act via 
the phospholipase-C pathway leading to an increase in intracellular inositol triphosphate 
(IP3) which can signal downstream to cause Ca2+ release from the sarcoplasmic 
reticulum,  intracellular store of Ca2+ (Webb, 2003).  
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Once Ca2+ is released, it binds to a protein called calmodulin. This Ca/calmodulin 
complex functions to activate the myosin light chain kinase (MLCK), which 
phosphorylates the myosin light chain. Once phosphorylated, the myosin light chain 
hydrolyzes ATP due to its myosin-Mg2+ATPase activity, increasing the myosin light 
chain’s affinity to actin allowing for myosin to bind actin and providing energy for cross-
bridge cycling. When looking at the GI tract specifically, Ca2+/calmodulin-dependent 
myosin light-chain kinase(MLCK) phosphorylation of Ser19 on the 20-kDa regulatory 
light chain of myosin II (MLC20) is vital for initiating smooth muscle contraction (Patel et 
al, 2006). However this initiation of Ca2+ dependent contraction and MLCK activity is 
transient and short-lived. Sustained contraction and MLC20 phosphorylation only occurs 
through the inhibition of MLC phosphatase (MLCP) is known as the Ca2+ independent 
phase (Murthy, 2006). The small G protein RhoA and its downstream target Rho kinase 
play an imperative part in the regulation of MLCP activity. MLCP inhibition occurs via 
two RhoA-dependent pathways. The first one involves by Rho kinase dependent 
phosphorylation of MYPT1, the regulatory subunit of MLC phosphatase. The second 
mechanism involves PKC dependent phosphorylation of the MLCP inhibitor, CPI-17 
(Patel et al, 2006) (Seko et al, 2003).  
 
Signaling Mechanisms in Smooth Muscle Relaxation 
In order for smooth muscle to relax a reduced intracellular Ca2+ concentration 
and up-regulation of MLCP’s dephosphorylating activity is required. Relaxation of the GI 
smooth muscle is induced through inhibitory neurotransmitters through the generation of 
cAMP and cGMP and activation of cAMP dependent protein kinase (PKA) or cGMP-
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dependent protein kinase (PKG). The kinases, PKA and PCG, act downstream to 
decrease intracellular Ca2+ levels leading to dephosphorylation of MLC20 and 
eventually relaxation of smooth muscle. An example of these inhibitory 
neurotransmitters is nitric oxide (NO), which acts through the cGMP pathway. NO 
formed in nerve terminals modulates VIP (vasoactive intestinal peptide) release. VIP 
functions to stimulate eNOS (nitric oxide synthase III) to generate NO in endothelial 
cells which then diffuses to smooth muscle. NO in smooth muscle cells stimulates the 
cGMP signaling cascade to cause relaxation of smooth muscle (Murthy, 2006). 
 
Excitation-Transcription Coupling 
Calcium (Ca2+) signals affect not only contraction, but also mediate gene 
transcription in smooth muscle and many other physiological processes. Ca2+–cyclic 
AMP response element binding protein (CREB) and nuclear factor of activated T-cells 
(NFAT) are two of the most well studied Ca2+-regulated smooth muscle transcription 
factors. Studies have presented many commonalities and differences in the regulation 
of CREB and NFAT through Ca2+ influx leading to expression of smooth muscle cell 
specific differentiation and proliferation markers.  
CREB controls transcription through binding to Ca2+–cyclic AMP (cAMP)-
response elements (CREs), which are located in the promoter of several genes. In order 
for activation and recruitment of CREB binding protein (CBP300) to form an active 
transcriptional complex, phosphorylation of 133serine must occur. Depolarization-
mediated CREB phosphorylation has been associated with increased transcription of c-
fos, the CRE-containing immediate early gene, and has also been found to be impacted 
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by inhibitors of voltage gated Ca2+ channels. However, every Ca2+ signal does not lead 
to activation of CREB. Ca2+ released from ryanodine receptors (RyR) has been shown 
to have an inhibitory effect on CREB activation. These findings propose the nature of 
the Ca2+ signal has great significance on the downstream changes in gene transcription 
mediated by CREB. 
Likewise, NFAT has also recently been indicated to play an essential role in in 
the regulation of excitation-transcription coupling in smooth muscle. Upon increased 
intracellular Ca2+ levels, calcineurin, the Ca2+–CaM-dependent phosphatase, 
dephosphorylates NFAT which translocates the NFAT–calcineurin complex into the 
nucleus. NFAT translocation and transcriptional activity has been distinctly established 
in both cultured and native smooth muscle cells.  
The serum response factor (SRF) DNA binding site or CArG box (CC[A/T]6GG) 
has also been shown to have an imperative role in regulating smooth muscle specific 
genes. Voltage gated Ca channels allow for Ca2+ influx upon depolarization which 
stimulates expression of SRF-dependent smooth muscle differentiation markers. This 
mechanism involves both Rho kinase and the SRF coactivator myocardin. The clearly 
suggests co-activators as well as CREB and NFAT have the capacity to direct 
expression of SRF-regulated genes in response to Ca2+ signaling in smooth muscle 
cells (Barlow et al., 2006.) 
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Pathogenesis in DMD 
The primary defect of DMD is well established.  However, the mechanisms that 
initiate pathogenesis have not been clearly characterized.  Plasma membrane fragility 
and damage due to mechanical stretch are important factors facilitating diseases, but 
these mechanisms do not fully explain the onset and progression of the disease. Altered 
intracellular signaling and augmented inflammation and immune response appear to 
contribute to the disease onset and progression. Previous studies have shown that 
calcium plays a significant role in DMD.  Without dystrophin, the plasma membrane 
becomes more susceptible to contraction-induced damage resulting in tears and breaks 
in the membrane. This leads to an increased membrane permeability and an influx of 
calcium (Ca2+) through these breaks. Ca2+ will travel into the myocyte and bind to Ca2+ 
dependent proteases. Ca2+ dependent proteases are thought to accelerate myocyte 
death when coupled with DMD. Ca2+ can also lead to mitochondrial dysfunction causing 
a release of reactive oxygen species (ROS). The exact process underlying this 
mechanism is not well known however, elevated levels of ROS and oxidative stress 
have been associated in the pathophysiology of DMD (Choi et al., 2015).   Inflammatory 
gene expression profile in mdx muscle is closely similar (~70%) to that observed in 
DMD patients.  Treatment of mdx mice with the anti-oxidant N-acetyl cysteine 
decreased oxidative stress and protected the muscle fiber from stretch-induced damage 
(Hori et al., 2011).  In addition, currently available treatment options for DMD are 
glucocorticoids and the most the significant effect of glucocorticoids is to inhibit 
expression of inflammatory genes.   
 
 
25 
Hydrogen Sulfide (H2S) 
Historically, hydrogen sulfide (H2S) has been known as a deadly and toxic gas. 
However, H2S has recently been accepted into the family of endogenously produced 
gasotransmitters which includes nitric oxide (NO) and carbon monoxide (CO) (Hartle 
and Pluth, 2016). The molecular weight of hydrogen sulfide (H2S) is 34.076 g/mol and is 
known to have a strong odor of rotten eggs. The boiling point of the compound is -60.02 
degrees celcius and the melting point is 82.3 degrees Celsius. The vapor density for 
H2S is 1.19 (Wang, 2012). H2S can be enzymatically generated from cysteine 
metabolism by the three enzymes cystathionine γ-lyase (CSE), cystathionine-β-
synthase (CBS), and 3-mercaptopyruvate sulfurtransferase (3-MST) / cysteine 
aminotransferase (CAT) (Hartle and Pluth, 2016). It has been demonstrated in vascular 
smooth muscle cells, where hydrogen sulfide is mainly synthesized by CSE, whereas it 
is predominantly synthesized by CBS in the central nervous system and by 3-MST in 
cardiac tissues (Kamoun, 2004).  
H2S levels ranging from 50-160 micromolar have been observed in some 
mammals and even the human brain (Wang, 2012) implying physiological importance. 
H2S has been shown to have anti-oxidant, anti- inflammatory, vasorelaxant and many 
other physiological properties (Hu et al., 2010) (Kamoun, 2004).  Hydrogen sulfide can 
also act as a neuromodulator by mediating NMDA receptor responses and also 
possesses vasorelaxant properties in smooth muscle by enhancing the effects of nitric 
oxide by up to 13-fold. (Kamoun, 2004). When specifically looking at the GI tract, H2S 
has been shown to increase gastric mucosal blood flow and also support maintenance 
of gastric mucosal integrity in rats treated with nonsteriodal anti-inflammatory drugs 
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(NSAIDs), which are known to compromise gastric mucosal blood flow (Fiorucci, et al, 
2006). 
 
H2S as an Antioxidant:  Hydrogen sulfide (H2S) exerts a wide range of 
physiological and cytoprotective functions such as neuroprotection, cardioprotection and 
antihypertension (Xie et al, 2016). Specifically, the role of H2S in oxidative stress has 
gained a lot of attention. H2S is a strong reducing agent that interacts with reactive 
oxidative species. This effect contributes to the antioxidant role of H2S. It is plausible 
that endogenous H2S can scavenge reactive oxygen species to protect against 
oxidative stress. However, studies demonstrate that instead of functioning directly as an 
antioxidant, H2S increases intracellular reduced glutathione (GSH) levels to protect 
neurons from oxidative stress. GSH is a very potent antioxidant that serves many 
protective functions such as shielding neurons from glutamate toxicity. Endogenous 
levels of GSH are 1–8 mM while those of H2S are 50–160 μM. Consequently, due to 
these low levels of H2S, H2S itself cannot alleviate cells of oxidative stress and must 
stimulate production of the more abundant antioxidant, GSH (Kimura and Kimura, 
2004).  
H2S exhibits a cardioprotective role, through its antioxidant properties, on the 
cardiovascular system specifically when looking at heart failure. S-propargyl-cysteine 
(SPRC), a modulator of endogenous hydrogen sulfide levels, is designed to act by 
stimulating the activity of cystathionine-γ-lyase (CSE), which as mentioned previously, is 
a metabolic enzyme that produces hydrogen sulfide. Studies have shown that 
administration of SPRC in rats with chronic heart failure conserved the level of 
antioxidant molecules such as GSH and also preserved cardiomyocyte membrane 
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integrity, preventing the leakage of metabolic enzymes such as creatine kinase (CK). 
This study demonstrates that the administration of H2S as SPRC in myocardium may 
exhibit a cardioprotective role through maintaining the balance of oxidative stress 
associated with the development of heart failure. (Huang et al., 2013). 
H2S may also exhibit a gasoprotective role through its antioxidative properties. 
The antioxidant function in the GI tract of H2S can be mediated by increasing the 
expression of enzymes such as superoxide dismutase, glutathione peroxase dismutase, 
and thioredoxin (Wallace et al, 2012). In previous studies, NaHS, an H2S donor was 
shown to increase the expression of potent antioxidative enzymes such as superoxide 
dismutase and glutathione peroxase dismutase. Moreover, there was a significant 
reduction in intestinal ischemia-reperfusion injury and also decreased intestinal MDA 
activity, which is a marker of radical injury, in rats (Liu et al., 2009). In addition to its role 
in the intestine, endogenous H2S also protects against oxidative stress in gastric 
ischemia-reperfusion injury in a similar manner (Cui et al., 2012).  
 
Regulation of smooth muscle function by H2S:  While gastric mucosa 
expresses both CSE and CBS, CSE appears to play a major role in H2S generation. 
The mechanism through which H2S exerts its relaxant properties is not fully understood, 
although it is likely mediated by the opening of K+ATP channels. It is thought that in 
vascular smooth muscle cells, the opening of K+ATP channels hyperpolarizes the cell 
membrane. This results in the inactivation of voltage-dependent L-type Ca2+ channels, 
which results in relaxation. H2S -induced vasorelaxation has been established in the 
aorta, portal vein, mesenteric artery, cerebral arteries and vas deferens from many 
different species including humans (Wang, 2012).  Additionally, H2S relaxes smooth 
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muscle in the colon through the same mechanism via K+ATP channels. H2S has also 
been known to enhance the smooth muscle relaxant effect of Nitric Oxide (NO). While 
the primary observed outcome of H2S in smooth muscle is relaxation, it is noteworthy 
that H2S can exert potent contractile responses in certain tissues and species (Fiorucci, 
et al, 2006). It has been demonstrated that H2S produces excitatory motor responses in 
the rat urinary bladder by activating capsaicin-sensitive primary afferent neurons 
(Patacchini et al., 2004)  
 
Mouse models: mdx mice versus mdx/mTR mice 
As previously mentioned, DMD is due to a mutation in the dystrophin gene, which 
has been shown to lead to fatal skeletal muscle degeneration. Several animal models of 
DMD have been developed over the last 35 years and mdx mice are the most 
commonly employed animal models in studies to understand the pathophysiology of 
DMD.  Dystrophin deficiency, however, does not display the same severity of DMD in 
mice (mdx), which only exhibit mild skeletal muscle defects and this could be due to 
species-specific up-regulation of compensatory mechanisms.  A number of mouse 
models with more severe dystrophic phenotypes have been created and these include 
double KO mice lacking dystrophin and utrophin, MyoD, α7integrin, α-dystrobrevin or 
glycan processing. Later studies showed that species-specific differences in the 
telomere length account for the differences in the disease severity. Telomerase 
consisting protein telomerase reverse transcriptase and telomerase RNA component 
(TERC or mTR) maintains the length of the telomeres.  In order to achieve an animal 
model with severe muscular dystrophy that more closely resembles DMD that occurs in 
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humans, a telomerase mutation is added to the dystrophin mutation (mdx/mTR) 
resulting in double knockout mice. A lack in the RNA for telomerase causes shortened 
telomeres, which contribute to the progression of DMD severity with age and this more 
closely represents the symptoms we see in human DMD (Rodrigues et al., 2016). 
Compared to single KO mice, the double KO mouse models exhibit exacerbated 
disease phenotypes based on various criteria such as increased serum creatine kinase 
levels, skeletal muscle fibrosis, exhaustion of mice on treadmill, kyphosis, skeletal and 
cardiac muscle myopathies and shortened life span (Yucel et al., 2018). 
 
Rationale and Hypothesis 
Gastrointestinal complications are common in DMD. The mechanisms underlying 
the gastrointestinal motility dysfunction in DMD are unknown.  It is our hypothesis that 
dystrophin deficiency in DMD leads to a decrease in the level of contractile protein 
expression and gastric smooth muscle function. The aim of this study was to determine 
the levels of thin-filament associated proteins such as caldesmon, calponin, 
tropomyosin, and smoothelin while also assessing gastric smooth muscle function in 
using 2 mouse model of DMD, mdx and mdx/mTR.  
Altered Ca2+ levels in DMD may lead to mitochondrial dysfunction and ROS 
production.  ROS have been associated in the pathophysiology of DMD.  Oxidative 
stress has been shown to cause changes in the levels of thin filament-associated 
proteins in visceral smooth muscle. We also hypothesized that due to its anti-oxidant 
properties, treatment with H2S will restore the level of contractile protein expression and 
smooth muscle function.  
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Chapter 2- MATERIALS AND METHODS 
 
Reagents: 
RNAqueousTM kit, TRIzol Reagent, High-capacity cDNA Reverse Transcription 
Kit, PCR Primers for Calponin (Cnn1 Mm00487032-m1 59 bp), Caldesmon 
(Cald1Mm00513995-m1 102 bp), Tropomyosin (Tpm2 Mm00437172-g1 97 bp), 
Smoothelin (Smtn Mm00449973 m1 66 bp), GAPDH (NM-008084.2 107 bp), β-actin 
(Actb Mm02619580-g1), and 18-S (4332641) were obtained from Thermo Fisher 
(Waltham, MA); Antibodies for Calponin, Caldesmon, and Smoothelin were obtained 
from Abcam (Cambridge, MA). Antibodies for Tropomyosin were obtained from Santa 
Cruz Biotechnologies, Inc. (Dallas, TX); GAPDH was obtained from Cell Signaling 
Technology (Danvers, MA). Western blotting materials, 2x Laemmli Sample Buffer, 
Clarity MaxTM Western ECL Substrate and DCTM Protein Assay Reagents were obtained 
from Bio-Rad Laboratories (Hercules, CA); SuperSignal® Western Blotting materials, 2x 
Laemmli Sample Buffer,  DCTM Protein Assay Reagents, Clarity Max Western ECL 
Substrate, Clarity Western ECL were obtained from Bio-Rad Laboratories (Hercules, 
CA). T-PER® Tissue Protein Extraction Reagent was obtained from Thermo Scientific 
(Rockford, IL). All other supplies from Sigma (St.Louis, MO); and Fisher Scientific, 
(Asheville, NC).  
 
Animals 
9-month-old male wild type, mdx/mTR and mdx/mTR treated with SG1002 were 
received from Dr. Solloum. mdx/mTR mice in Dr. Salloum’s lab were treated with 
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SG1002, an orally active slow-releasing H2S pro-drug. SG1002 was administered at 21 
days old to 9 months (40 mg/kg of body weight in chow/every 3 days in mdx/mTR mice). 
3-month old wild-type and mdx female mice (C57BL/6) were purchased from 
Jackson Laboratories (Sacramento, California). The mice were housed in an animal 
facility directed by the Division of Animal Resources at Virginia Commonwealth 
University. They were euthanized by asphyxiation by carbon dioxide (CO2) under 
approval by the Institutional Animal Care and Use committee of Virginia Commonwealth 
University. 
 
Preparation of dispersed smooth muscle cells.   
Smooth muscle cells were isolated from mouse stomach by sequential enzymatic 
digestion, filtration, and centrifugation. The mucosa of the gastric tissue was carefully 
removed and the tissue was chopped via surgical shears. It was then incubated at 31°C 
for 10-15 minutes in SMB [NaCl 120 mM, KCl 4 mM, KH2PO4 2.6 mM, CaCl2 2.0 mM, 
MgCl2 0.6 mM, HEPES (N-2-hydroxyethylpiperazine-N’ 2-ethanesulfonic acid) 25 mM, 
glucose 14 mM, and Basic Eagle Medium (essential amino mixture) 2.1% (pH 7.4)] 
containing 0.1 % collagenase and 0.01% of soybean trypsin inhibitor. The partially 
degraded tissue was washed once with collagenase-free SMB and permitted to 
disperse spontaneously for 20 minutes. Cells were then collected utilizing a 500 um 
Nitex every 10 minutes.  
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Measurement of contraction and relaxation in freshly isolated muscle cells. 
Contraction in freshly dispersed gastric smooth muscle cells was determined by 
scanning micrometry. Freshly isolated muscle cells aliquots (10-4cells/ml) were treated 
with 0.5ml of medium containing 10 µM acetylcholine for 30 s or 5 minutes and the 
reaction was terminated with 1% acrolein at a final concentration of 0.1%. The resting 
cell length was determined in control experiments in which muscle cells were incubated 
with 0.5ml of 0.1% bovine serum albumin in the absence of the ACh. The mean lengths 
of 50 muscle cells treated with 10 µM acetylcholine was measured by scanning 
micrometry and compared with the mean lengths of untreated cells. ACh induced 
contraction was expressed as the percent decrease in mean cell length from control cell 
length. 
Relaxation was also examined in intact muscle cells contracted with   1 μM ACh. 
Muscle cells were treated for 5 minutes with 10 μM SNP or 10 μM isoproterenol 
followed by ACh for 30 s or 5 min. The reaction was terminated with 1% acrolein. The 
length of 50 cells treated with acetylcholine was measured in sequential microscopic 
fields by scanning micrometry. Relaxation was expressed as percent increase in the 
length of cells contracted with ACh. 
 
Preparation of gastric smooth muscle strips 
1 L of Krebs buffer  [118 mM NaCl, 4.8 mM KCl, 1 mM MgSO4, 1.15 mM 
NaH2PO4, 15 mM NaHCO3, 10.5 mM glucose and 2.5 mM CaCl2 (95% O2/5% CO2, pH 
7.4, 37°C) was prepared. Mice were euthanized with CO2 inhalation, vertical abdominal 
incisions were made, and the stomach was removed and placed into a beaker 
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containing Krebs buffer. Gastric contents were removed with a syringe filled with Krebs 
buffer. The mucosa was removed and strips were cut from the fundus of the stomach.  
Each end of the muscle strip was tied using a silk thread and mounted vertically on 
organ baths that were kept oxygenated (95% O2 and 5% CO2) at 37 degrees Celsius. 
Each organ bath was filled with either 7ml or 3.5 ml of Kreb’s (depending on the size of 
the organ bath). One side of the strip was hooked onto the transducer and the other 
side was hooked onto a glass rod.  
Every 15 min, Krebs buffer was flushed and refilled and the preparations were 
allowed to equilibrate for 1 hour at a resting tension of 0.7-0.8 grams. Contraction was 
induced via muscarinic receptor activation (acetylcholine) at a concentration of 10 µM of 
acetylcholine (ACh). Relaxation was measured in response to 10 µM of sodium-
nitroprusside (SNP), a NO donor. The contractile response of the gastric segments to 
muscarinic receptor activation was measured and expressed as an increase in tension 
in grams. SNP induced relaxation was calculated as percent decrease in maximum 
contraction. After completion of the experiment, the strips were taken down, blotted dry 
with a kimwipe and the tissue wet weight (7mg ± 0.8) was obtained.  
 
Western blot analysis of thin filament-associated proteins 
Gastric smooth muscle tissue was taken from animal models. The tissue was 
cleaned and the mucosa was removed. This tissue was then transferred into new tubes 
with appropriate amounts of 1.44mm beads and TPER (lysis buffer) in the presence of 5 
µL of protease inhibitor. Bead number was calculated as 5 times the tissue weight. 
TPER was then added and was calculated as two times the tissue weight. Tissues were 
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homogenized using a bullet blender. The supernatant was collected and centrifuged at 
13.3 rpm at 4°C for 10 minutes. The supernatant was transferred to new tubes and the 
protein concentration was then measured using a DC protein assay kit from Bio-Rad. 
Equal amounts of proteins were fractionated by SDS/PAGE, and transferred on to 
Polyvinylidene difluoride (PVDF) membrane.  Blots were blocked with 1X TBS with 1% 
casein blocker for 1 hour at room temperature and then incubated overnight at 4 °C with 
primary antibodies in 1X TBS with 1% casein (Calponin 1:5000, Tropomyosin 1:1000, 
Caldesmon 1:10,000, Smoothelin 1:5000). The following morning the membranes were 
washed with TBS-T and incubated for 1 hour with horseradish-peroxidase-conjugated 
corresponding secondary antibody (1:5000) in 1X TBS with 1% casein. Immunoreactive 
proteins were visualized using Clarity Max Western ECL Substrate, Clarity Western 
ECL Substrate, or SuperSignal West Pico Chemiluminescent Substrate kit. Enhanced 
chemiluminescence reagent identified the protein bands. 
 
Qualitative Real Time PCR  
25-50 mg of gastric tissue was isolated from mice stomach and transferred to a 
tube with 1 ml of TRIzol. The mixture was homogenized via Fisher PowerGen 125 
homogenizer. 0.2 ml of chloroform was added. The tubes were vortexed, incubated at 
room temperature for 5 min and then centrifuged at 13.3rpm for approximately 5 min. At 
the end of centrifugation the mixture separates into two distinct layers, a lower red, 
phenol-chloroform phase and an upper clear aqueous phase. The RNA containing 
upper aqueous phase was carefully transferred into a new autoclaved 1.5ml tube. RNA 
was precipitated from the aqueous phase by adding 0.5 ml of isopropyl alcohol. The 
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mixture was then centrifuged at 13.3rpm for 20 min at 4°C and the precipitated RNA 
appeared as a white pellet. The pellet was washed with 1 ml of 70% ethanol, mixed by 
vortexing and centrifuged at 13.3 for 10 min at 4°C and completely vacuum dried. 
RNase and DNase free ultrapure distilled water (25 µL) is added once the pellet is 
completely dry and the samples are then left to incubate at 65°C for 10 minutes. 
Immediately following incubation the samples are placed on ice. The concentration was 
measured with a NanoDrop 8000.  
cDNA was prepared by reversely transcribing RNA from each preparation using 
the High Capacity cDNA reverse transcription kits to prepare the 2x RT Master Mix 
[10xRT Buffer, 25x dNTP Mix, 10x RT Random primers, Multiscribe Reverse 
Transcriptase, Nuclease Free H 2 ].  An equal volume of RNA was added to 2xRT 
Master Mix. Quantitative RT-PCR was then performed on cDNA samples using the 
primers specific to tropomyosin, caldesmon, calponin, and smoothelin, based on known 
sequences in mouse and Taqman gene expression master mix. 18-S and β-actin were 
used to normalize expression of the target genes. Each real-time PCR reactions were 
performed in triplicate. With 18-S/β-actin acting as controls, a quantitative comparison 
between mdx, mdx/mTR, and mdx/mTR treated with SG1002 and their age-matched 
control was calculated using the 2 -∆∆CT method. Final calculations were expressed as 
a fold difference in the expression of mdx, mdx/mTR, and mdx/mTR treated with 
SG1002 mice cohorts relative to their age-matched control. 
Statistical Analysis 
 Results were expressed as means ± standard error of the mean of n 
experiments. Each experiment was performed on tissues obtained from different 
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animals. Experiments were designed to compare treatment to control conditions, with 
each individual strip serving as its own control. Paired t-tests were conducted in 
GraphPad Software Prism 6 (La Jolla, CA) with significance set at P<0.05.  
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Chapter 3: RESULTS 
 
1. Effect of dystrophin deficiency on gastric smooth muscle function.   
 Dystrophin deficiency in DMD patients and mouse models such as mdx is 
associated with delayed gastric emptying suggesting altered gastric motility.  However, 
the role of dystrophin in gastric smooth muscle function is not known.  To investigate the 
role of dystrophin in normal smooth muscle function, muscle contraction and relaxation 
was measured in both muscle strips and isolated muscle cells.   
Contraction in gastric muscle strips. Contraction in response to the main 
excitatory transmitter acetylcholine (ACh) was measured. Experiments were carried out 
in gastric muscle strips on 3-month old control and mdx mice.  The strips were mounted 
in organ bath and after equilibration of 1 g of resting tension, 10 µM of ACh was added.  
Addition of ACh to the bath medium caused a rapid contraction that reached a plateau 
of sustained contraction.  Contraction was recorded as increase in tension in grams 
above basal tension.  In the gastric muscle strips from control mice ACh caused 1.0±0.2 
g of contraction and in the gastric muscle the strips from mdx mice ACh caused 0.5±0.2 
g of contraction (Figure 2).  Contraction in grams was normalized to tissue weight and 
presented as mN/100 mg tissue.  Gastric muscle contraction was significantly inhibited 
in mdx mice.  ACh-induced contractions in gastric muscle strips controls mice was 45±4 
mN/100 mg tissue, whereas in gastric muscle strips from mdx mice contraction in 
response to ACh was 24±5 mN/100 mg tissue (Figure 2) (p<0.05, n=4-5).  
Although mdx mice were extensively used, this model exhibits only mild 
phenotype compared to DMD patients.  Recent studies have developed a more 
humanized mouse model, mdx/mTR, that lacks both dystrophin and telomerase RNA 
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component. This model exhibits exacerbated disease phenotype and closely 
approximated human DMD. Dr. Salloum’s group at Virginia Commonwealth University 
has shown that the abnormalities in cardiac function were more robust in this model and 
treatment of mdx/mTR mice with treated with SG1002, an orally active slow-releasing 
compound that provides stable, non-toxic serum and tissue levels of H2S, provided 
cardioprotection.   Gastric tissues from 9-month old control and mdx/mTR mice, and 
mdx/mTR mice treated with SG1002 obtained Dr. Salloum laboratory were used to 
examine gastric muscle function  
Contraction in response to ACh was also significantly decreased in gastric 
muscle strips from mdx/mTR mice compared to their age-matched control (32.3±6.8 
mN/100 mg tissue in control and 17.7±3.8 mN/100 mg tissue in mdx/mTR mice; p<0.05, 
n=4) (Figure 3). These results suggest that H2S completely reversed the decrease in 
smooth muscle contraction in mdx/mTR mice.  
Relaxation in gastric muscle strips.  Changes in smooth muscle relaxation 
also affects gastric motility. Nitric oxide (NO) is the inhibitory transmitter in the 
gastrointestinal tract.  Relaxation in response to NO donor, sodium nitroprusside (SNP) 
was measured as inhibition of ACh-induced contraction in gastric muscle strips.  To 
examine the effect of SNP on ACh-induced contraction, gastric muscle strips were 
treated with ACh (10 µM) to increase the tension and after the tension plateaued, SNP 
(10 µM) was added to induce inhibition of sustained tone and the inhibition of 
contraction was calculated as percent relaxation.  SNP induced relaxation in muscle 
strips from control and mdx mice.  The effect of SNP to induce relaxation was not 
different between control and mdx mice (control: 86±3% decrease in contraction; mdx: 
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88±4% decrease in contraction) (Figure 4). Similarly SNP-induced relaxation was not 
different in muscle strips from control and mdx/mTR mice and mdx/mTR mice treated 
with SG1002 (control: 85±3%; mdx/mTR: 91±2%; mdx/mTR treated with SG1002: 
95±7% decrease in contraction) (Figure 5).  These results suggest that, unlike 
contraction in response to ACh, relaxation in response to NO donor was not affected in 
gastric muscle of mdx and mdx/mTR mice.   
Contraction in isolated muscle cells.  The results in mdx and mdx/mTR mice 
suggest that lack of dystrophin impairs gastric muscle contraction. One of the limitations 
of the studies in muscle strips is involvement of multiple cell types.  Although decreased 
response to ACh in gastric muscle strips from mdx and mdx/mTR mice suggest 
changes in response in post-synaptic cells, the involvement of enteric neuros and 
interstitial cells of Cajal (ICC) cannot be excluded.  To preclude the effects of enteric 
neurons and ICC and see the direct effect of dystrophin deficiency on smooth muscle 
function, gastric muscle cell devoid of enteric neurons and ICC were prepared and 
contraction in response to ACh was measured by scanning micrometry in dispersed 
muscle cells.  Experiments were carried out in gastric muscle cells isolated from 3-
month old control and mdx mice.  Previous studies have shown that contraction in 
gastric muscle cells, as in muscle strips, in response to several contractile agonists is 
biphasic. A rapid initial peak contraction reflecting activation of Ca2+/calmodulin-
dependent myosin light chain (MLC) kinase activity and a sustained Ca2+-independent 
phase reflecting inhibition of MLC phosphatase activity has been seen.  Activation of 
MLC kinase initiates phosphorylation of MLC20, a prerequisite for muscle contraction, 
whereas inhibition MLC phosphatase sustains MLC20 phosphorylation and muscle 
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contraction. Dispersed gastric muscle cells were treated with ACh (1 µM) for 0.5 min to 
measure initial contraction and for 5 min to measure sustained contraction.  Contraction 
was measured as decrease in cells length compared to basal cell length.   
 The basal cell lengths of colonic smooth muscle cells were not significantly 
different in control mice and mdx mice (63±3 µm in control mice and 67±5 µm in mdx 
mice).  Treatment with ACh for 0.5 min caused a significant decrease in cell length in 
muscle cells isolated from the stomach of control and mdx mice.  However, the 
contraction in response to ACh was significantly inhibited in muscle cells from the 
stomach of mdx mice compared to control mice (40±4% decrease in cell length in 
control mice and 24+3% decrease in muscle cell length in mdx mice; p<0.05, n=4-5) 
(Figure 6).  Treatment with ACh for 5 min also caused a significant decrease in cell 
length in muscle cells isolated from the stomach of control and mdx mice.  However, the 
contraction in response to ACh was significantly inhibited in muscle cells from the 
stomach of mdx mice compared to control mice (41+4% in control and 25+2 in mdx 
mice; p<0.05, n=4-5) (Figure 7).   The results in isolated muscle cells are consistent with 
the results in muscle strips and provide evidence that lack of dystrophin affects smooth 
muscle contraction.   
Relaxation in isolated muscle cells.  In contrast to an increase in MLC20 
phosphorylation, which mediates acto-myosin interaction and muscle contraction, 
decrease in MLC20 phosphorylation mediates muscle relaxation.  The main inhibitory 
transmitters are nitric oxide, which causes relaxation via activation of soluble guanylyl 
cyclase, generation of cGMP and activation of cGMP-dependent protein kinase (PKG), 
and vasoactive intestinal peptide, which causes relaxation via activation of Gs-coupled 
 
41 
adenylyl cyclase, generation of cAMP and activation of cAMP-dependent protein kinase 
(PKA).  We next examined whether lack of dystrophin affects the pathways that mediate 
muscle relaxation, Sodium nitroprusside, a NO-donor that activates soluble guanylyl 
cyclase and cGMP/PKG pathway, and isoproterenol, an agonist that activates β-
adrenergic receptor coupled to Gs and activation of adenylyl cyclase, cAMP/PKA 
pathway were used.  Experiments were carried out in gastric muscle cells isolated from 
3-month old control and mdx mice.   
To measure relaxation, muscle cells were pretreated with SNP (10 µM) or 
isoproterenol (10 µM) for 5 min and initial contraction in response to ACh (1 µM) was 
measured.  Inhibition of contraction in response to ACh in the presence of SNP or 
isoproterenol was considered as relaxation.  Relaxation in response to SNP was not 
significantly different in muscle cells isolated from the stomach of control and mdx mice.  
SNP caused 82±10% relaxation in muscle cells from control mice and 76±7% relaxation 
in muscle cells from mdx mice (Figure 8).  Relaxation in response to isoproterenol also 
was not significantly different in muscle cells isolated from the stomach of control and 
mdx mice.  Isoproterenol caused 86±9% relaxation in muscle cells from control mice 
and 74±8% relaxation in muscle cells from mdx mice (Figure 9). These results suggest 
that either NO-dependent relaxation mediated via cGMP/PKG pathway or Gs-coupled 
receptor relaxation mediated via cAMP/PKA pathways mediated was not affected in 
gastric muscle cells from mdx mice.    
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Figure 2.  Inhibition of gastric muscle contraction in mdx mice.  Gastric muscle 
strips were isolated from 3-month old control and mdx mice. Contraction in response to 
acetylcholine (ACh, 10 µM) was measured in organ bath experiments. Contraction was 
recorded as increase in grams and calculates as mN/100g mg tissue.  Left panel: Bar 
graphs of calculated values representing mean ± SEM of 4-5 separate experiments. 
Right panel: Representative tracing of acetylcholine-induced contraction in gastric 
muscle strips from control and mdx mice.  Contraction was significantly decreased in 
mdx mice (** p <0.05) 
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Figure 3.  Inhibition of gastric muscle contraction in mdx/mTR mice and reversal 
of inhibition by H2S. Gastric muscle strips were isolated from 9-month old control and 
mdx/mTR mice and mdx/mTR mice treated with SG1002, an orally active H2S donor. 
Contraction in response to acetylcholine (10 µM) was measured in organ bath 
experiments. Contraction was recorded as increase in grams and calculated as 
mN/100g mg tissue.  Values are mean ± SEM of 4 separate experiments. Contraction 
was significantly decreased in mdx/mTR (** p <0.05).  Treatment with SG1002 
completely reversed the inhibition in contraction (## p < 0.05).  
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Figure 4.  SNP-induced relaxation in gastric muscle cells from control and mdx 
mice. Gastric muscle strips were isolated from 3-month old control and mdx mice. 
Relaxation in response to nitric oxide donor, sodium nitroprusside (SNP, 10 µM) was 
measured as inhibition of acetylcholine (10 µM)-induced contraction and calculated as 
percent inhibition of contraction.  Values are mean ± SEM of 4 separate experiments.  
SNP-induced relaxation was not different between gastric muscle strips from control 
and mdx mice. 
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Figure 5.  SNP-induced relaxation in gastric muscle cells from control and mdx 
mice and mdx/mTR mice treated with SG1002. Gastric muscle strips were isolated 
from 3-month old control and mdx mice. Relaxation in response to nitric oxide donor, 
sodium nitroprusside (SNP, 10 µM) was measured as inhibition of acetylcholine (10 
µM)-induced contraction and calculated as percent inhibition of contraction.  Values are 
mean ± SEM of 4 separate experiments.  SNP-induced relaxation was not different 
between gastric muscle strips from control and mdx/mTR mice and mdx/mTR mice 
treated with SG1002. 
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Figure 6.  Inhibition of initial muscle contraction in gastric muscle cells from mdx 
mice.  Smooth muscle cells were isolated from the stomach of 3-month old control and 
mdx mice. Cells were treated with acetylcholine (1 µM) for 0.5 min and contraction was 
measured as decrease in cell length from the basal length (control: 63±3 µm and mdx: 
67±5 µM) and expressed as percent decrease in cell length. Values are mean ± SEM of 
4-5 separate experiments.  Initial contraction was significantly decreased in mdx mice 
(** p <0.05). 
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Figure 7.  Inhibition of sustained muscle contraction in gastric muscle cells from 
mdx mice.  Smooth muscle cells were isolated from the stomach of 3-month old control 
and mdx mice. Cells were treated with acetylcholine (1 µM) for 5 min and contraction 
was measured as decrease in cell length from the basal length (control: 63±3 µm and 
mdx: 67±5 µM) and expressed as percent decrease in cell length. Values are mean ± 
SEM of 4-5 separate experiments.  Sustained contraction was significantly decreased in 
mdx mice (** p <0.05). 
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Figure 8.  SNP-induced relaxation in gastric muscle cells from control and mdx 
mice. Smooth muscle cells were isolated from the colon of 3-month old control and mdx 
mice were pretreated with the nitric oxide donor, sodium nitroprusside (SNP, 10 µM) for 
5 min and contraction in repose to acetylcholine (1 µM) was measured.  Percent 
inhibition of ACh-induced contraction in the presence of SNP was presented as 
relaxation.  Values are mean ± SEM of 4-5 separate experiments.  SNP-induced 
relaxation was not different in colonic smooth muscle cells from both control versus mdx 
mice.  
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Figure 9.  Isoproterenol-induced relaxation in gastric muscle cells from control 
and mdx mice. Smooth muscle cells were isolated from the colon of 3-month old 
control and mdx mice were pretreated with the Gs-coupled β-adrenergic receptor 
agonist isoproterenol (10 µM) for 5 min and contraction in repose to acetylcholine (1 
µM) was measured.  Percent inhibition of ACh-induced contraction in the presence of 
isoproterenol was presented as relaxation.  Values are mean ± SEM of 4-5 separate 
experiments.  Isoproterenol-induced relaxation was not different in colonic smooth 
muscle cells from both control versus mdx mice.  
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2. Effect of dystrophin deficiency on the expression of thin filament-associated 
proteins 
The decrease in contraction could be due to changes in the intrinsic signaling 
pathways that regulate MLC20 phosphorylation or changes in the expression of proteins 
that regulate acto-myosin interaction.  Previous studies have that thin filament-
associated proteins regulate acto-myosin interaction.  Hence, studies were carried out 
to examine whether the expression of thin filament-associated proteins are altered in 
muscle cells in mdx mice.  Experiments were carried out in gastric muscle cells isolated 
from 3-month old control and mdx mice.  Expression of caldesmon, calponin, 
tropomyosin and smoothelin were measured by quantitative RT-PCR and western blot 
analysis.  
Caldesmon. Caldesmon is a thin-filament associated protein and shown to 
inhibit acto-myosin interaction and muscle contraction.  Expression of smooth muscle 
specific h-caldesmon was analyzed in gastric smooth muscle from control and mdx 
mice by qRT-PCR using specific primers.  The results showed that mRNA expression of 
caldesmon was significantly decreased in gastric smooth muscle from mdx mice 
compared to gastric smooth muscle control mice (p <0.05, n=4-5) (Figure 10). Western 
blot analysis using antibody that detect both muscle specific h-caldesmon or non-
muscle caldesmon demonstrated expression of h-caldesmon (~90 kDa) in gastric 
muscle and showed no difference in the expression between gastric muscle from 
control and mdx mice (Figure 10).  
Expression of caldesmon mRNA was also significantly decreased in gastric 
smooth muscle mdx/mTR mice compared to age-matched control mice (p<0.05, n=4). 
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Treatment of mdx/mTR mice with SG1002 significantly reversed the decrease in 
caldesmon expression (p<0.05, n=4) (Figure 11). 
Calponin. Calponin is also filament-associated protein expressed in smooth 
muscle and several types of non-muscle cells. Three isoforms of calponin (calponin 1, 
2, and 3) are present and all three isoforms bind actin and inhibit its interaction with 
myosin.  Calponin isoform is smooth muscle specific and plays a role in fine-tuning 
smooth muscle contractility.  Expression of smooth muscle specific calponin 1 was 
analyzed in gastric smooth muscle from control and mdx mice by qRT-PCR using 
specific primers.  The results showed that mRNA expression of calponin was 
significantly decreased in gastric smooth muscle from mdx mice compared to gastric 
smooth muscle control mice (p <0.05, n=4-5) (Figure 12). Western blot analysis using 
antibody that detects both muscle specific and non-muscle calponin demonstrated 
expression of calponin 1 (~35 kDa) in gastric muscle and showed no difference in the 
expression between gastric muscle from control and mdx mice (Figure 12). 
Expression of calponin 1 mRNA was also significantly decreased in gastric 
smooth muscle mdx/mTR mice compared to age-matched control mice (p<0.05, n=4). 
Treatment of mdx/mTR mice with SG1002 significantly reversed the decrease in 
calponin 1 expression (p<0.05, n=4) (Figure 13). 
Tropomyosin:  Smooth muscle tropomyosin exists in heterodimer of α/β 
isoforms, and unlike skeletal muscle, smooth muscle tropomyosin by itself augments 
actomyosin ATPase activity.  This action is in an opposite manner to that of caldesmon 
and calponin.  Expression of tropomyosin was analyzed in gastric smooth muscle from 
control and mdx mice by qRT-PCR using primers that are not isoform-specific.  The 
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results showed that mRNA expression of tropomyosin was significantly decreased in 
gastric smooth muscle from mdx mice compared to gastric smooth muscle control mice 
(p <0.05, n=4-5) (Figure 14). Western blot analysis using antibody demonstrated 
expression of tropomyosin (~70 kDa) in gastric muscle and showed no difference in the 
expression between gastric muscle from control and mdx mice (Figure 14). 
Expression of tropomyosin mRNA was also significantly decreased in gastric 
smooth muscle mdx/mTR mice compared to age-matched control mice (p<0.05, n=4). 
Treatment of mdx/mTR mice with SG1002 significantly reversed the decrease in 
tropomyosin expression (p<0.05, n=4) (Figure 15). 
Smoothelin.  Smoothelin is an important constituent smooth muscle 
cytoskeleton and a marker of fully differentiated contractile smooth muscle.  There are 
two isoforms of smoothelins, and their expression is tissue specific. Smoothein-A (~ 59 
kDa) is expressed in visceral smooth muscle and smoothelin-B (~110 kDa) is expressed 
in vascular smooth muscle.  Gene knockout studies demonstrated that smoothelin-A is 
essential for smooth muscle contraction in the gastrointestinal tract (Niessen et al., 
2005).  Expression of smoothein-A was analyzed in gastric smooth muscle from control 
and mdx mice by qRT-PCR using specific primers.  The results showed that mRNA 
expression of smoothelin-A was significantly decreased in gastric smooth muscle from 
mdx mice compared to gastric smooth muscle control mice (p <0.05, n=4-5) (Figure 16). 
Western blot analysis using antibody that detects both smoothelin-A and smoothelin-B 
demonstrated expression of both isoforms in gastric muscle and showed no difference 
in the expression between gastric muscle from control and mdx mice (Figure 16). 
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Figure 10.  Expression of caldesmon in gastric smooth muscle from control and 
mdx mice. Left Panel:  RNA was isolated from gastric smooth muscle of 3-month old 
control and mdx mice. mRNA expression of caldesmon was measured using specific 
primers by quantitative RT-PCR and expressed as fold change over control.  Values are 
mean ± SEM of 4-5 separate experiments.  mRNA expression of caldesmon was 
significantly decreased in gastric smooth muscle from mdx mice compared to control (** 
p<0.05). Right panel:  Lysates were prepared from gastric smooth muscle of control and 
mdx mice and expression of caldesmon was measured by western blot using specific 
antibody.  Representative western blot image of 4 separate experiments was shown in 
the figure.  Densitometry analysis of all the images showed no difference in the 
expression of caldesmon in gastric smooth muscle between control and mdx mice. 
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Figure 11.  Effect of H2S on caldesmon expression in gastric smooth muscle of 
mdx/mTR mice.  RNA was isolated from gastric smooth muscle of 9-month old control 
and mdx/mTR mice and mdx/mTR mice treated with SG1002, an orally active H2S 
donor. mRNA expression of caldesmon was measured using specific primers by 
quantitative RT-PCR and expressed as fold change over control.  Values are mean ± 
SEM of 4 separate experiments.  mRNA expression of caldesmon was significantly 
decreased in colonic smooth muscle from mdx/mTR mice compared to control (** 
p<0.05). Treatment with SG1002 significantly reversed the inhibition in caldesmon 
mRNA expression (## p<0.05).  
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Figure 12.    Expression of calponin in gastric smooth muscle from control and 
mdx mice. Left Panel:  RNA was isolated from gastric smooth muscle of 3-month old 
control and mdx mice. mRNA expression of calponin was measured using specific 
primers by quantitative RT-PCR and expressed as fold change over control.  Values are 
mean ± SEM of 4-5 separate experiments.  mRNA expression of calponin was 
significantly decreased in gastric smooth muscle from mdx mice compared to control (** 
p<0.05). Right panel:  Lysates were prepared from gastric smooth muscle of control and 
mdx mice and expression of calponin was measured by western blot using specific 
antibody.  Representative western blot image of 4 separate experiments was shown in 
the figure.  Densitometry analysis of all the images showed no difference in the 
expression of calponin in gastric smooth muscle between control and mdx mice. 
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Figure 13.  Effect of H2S on calponin expression in gastric smooth muscle of 
mdx/mTR mice.  RNA was isolated from gastric smooth muscle of 9-month old control 
and mdx/mTR mice and mdx/mTR mice treated with SG1002, an orally active H2S 
donor. mRNA expression of calponin was measured using specific primers by 
quantitative RT-PCR and expressed as fold change over control.  Values are mean ± 
SEM of 4 separate experiments.  mRNA expression of calponin was significantly 
decreased in colonic smooth muscle from mdx/mTR mice compared to control (** 
p<0.05). Treatment with SG1002 significantly reversed the inhibition in calponin mRNA 
expression (## p<0.05).  
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Figure 14.  Expression of tropomyosin in gastric smooth muscle from control and 
mdx mice. Left Panel:  RNA was isolated from gastric smooth muscle of 3-month old 
control and mdx mice. mRNA expression of tropomyosin was measured using specific 
primers by quantitative RT-PCR and expressed as fold change over control.  Values are 
mean ± SEM of 4-5 separate experiments.  mRNA expression of tropomyosin was 
significantly decreased in gastric smooth muscle from mdx mice compared to control (** 
p<0.05).  Right panel:  Lysates were prepared from gastric smooth muscle of control 
and mdx mice and expression of tropomyosin was measured by western blot using 
specific antibody.  Representative western blot image of 4 separate experiments was 
shown in the figure.  Densitometry analysis of all the images showed no difference in 
the expression of tropomyosin in gastric smooth muscle between control and mdx mice. 
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Figure 15.  Effect of H2S on tropomyosin expression in gastric smooth muscle of 
mdx/mTR mice.  RNA was isolated from gastric smooth muscle of 9-month old control 
and mdx/mTR mice and mdx/mTR mice treated with SG1002, an orally active H2S 
donor. mRNA expression of tropomyosin was measured using specific primers by 
quantitative RT-PCR and expressed as fold change over control.  Values are mean ± 
SEM of 4 separate experiments.  mRNA expression of tropomyosin was significantly 
decreased in colonic smooth muscle from mdx/mTR mice compared to control (** 
p<0.05). Treatment with SG1002 significantly reversed the inhibition in tropomyosin 
expression (## p<0.05).  
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Figure 16.  Expression of smoothelin in gastric smooth muscle from control and 
mdx mice. Left Panel:  RNA was isolated from gastric smooth muscle of 3-month old 
control and mdx mice. mRNA expression of smoothelin-A was measured using specific 
primers by quantitative RT-PCR and expressed as fold change over control.  Values are 
mean ± SEM of 4-5 separate experiments.  mRNA expression of smoothelin-A was 
significantly decreased in gastric smooth muscle from mdx mice compared to control (** 
p<0.05).  Right panel:  Lysates were prepared from gastric smooth muscle of control 
and mdx mice and expression of smoothelin was measured by western blot using 
specific antibody.  Representative western blot image of 4 separate experiments was 
shown in the figure.  Densitometry analysis of all the images showed no difference in 
the expression of smoothelin in gastric smooth muscle between control and mdx mice. 
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3. Summary of Results.  
• Contraction in response to acetylcholine was decreased in gastric muscle strips 
from mdx mice compared to age-matched controls.   
• Relaxation in response to SNP was not different between gastric muscle strips 
from control and mdx mice  
• Contraction in response to acetylcholine was also decreased in isolated gastric 
smooth muscle cells from mdx mice compared to age-matched controls.   
• Relaxation in response to SNP or isoproterenol was not different between gastric 
muscle cells from control and mdx mice  
• mRNA expression of caldesmon, calponin, tropomyosin and smoothelin was 
decreased in gastric smooth muscle from mdx compared to control mice. 
• Protein expression of caldesmon, calponin, tropomyosin and smoothelin mRNA 
was not different between gastric smooth muscle from control and mdx mice. 
• Contraction in response to acetylcholine was decreased in gastric muscle strips 
from mdx/mTR mice compared to age-matched controls.   
• mRNA expression of caldesmon, calponin, tropomyosin and smoothelin was 
decreased in gastric smooth muscle from mdx/mTR mice compared to age-
matched control mice. 
• Treatment of mdx/mTR mice with H2S releasing agent SG1002 reversed the 
decrease in the mRNA expression of caldesmon, calponin and tropomyosin and 
also muscle contraction to normal levels. 
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Chapter 4: DISCUSSION 
Dystrophin is an important structural protein present in skeletal, cardiac and 
smooth muscle and mutations in the dystrophin gene lead to complex diseases affecting 
several aspects of skeletal, cardiac and smooth muscle physiology. Deficiency of 
dystrophin due to a loss-of-function mutation in the dystrophin gene is the main genetic 
defect in Duchnne’s muscular dystrophy (DMD).  Clinical and experimental studies, in 
addition to the established skeletal and cardiac muscle disorders, have revealed motility 
disorders in the gut of DMD patients and in animal models of DMD.  The clinical 
manifestations of motility disorders in DMD patients include bloating, early satiety; 
feeling of fullness and constipation suggesting delayed gastric emptying and decreased 
intestinal motility.  The treatment recommended to relieve gastrointestinal symptoms are 
prokinetics that are mainly aimed at correcting motility disorders.  Despite the 
established role in skeletal and cardiac muscle, and the emerging role in vascular and 
airway smooth muscle biology, very little is known about the functional role of dystrophin 
in the gastric smooth muscle that is responsible for generating force for gastric motility 
and gastric emptying.  
In this study we hypothesized that dystrophin is a determinant of gastric smooth 
muscle function, and this underpins a role in determining gastric motility in vivo. We 
used mdx and mdx/mTR mice lacking dystrophin to perform biochemical and functional 
studies.  We measured isometric contraction studies ex vivo using gastric muscle strips. 
We also measured smooth muscle function using isolated muscle cells.  Acetylcholine 
was used as a contractile agonist as it is the main excitatory neurotransmitter in the gut. 
We examined the changes in the expression of calponin, caldesmon, tropomyosin and 
 
62 
smoothelin by qualitative RT-PCR and western blot comparing tissue from mdx and 
wild-type mice. We demonstrated that dystrophin is a determinant of gastric smooth 
muscle contraction, as there is a decrease in contraction in mdx mice compared to 
controls. This effect was associated with decrease in the expression of all thin-filament 
associated proteins in gastric smooth muscle cells.  
Our studies in muscle strips showed that contraction in response to acetylcholine 
was decreased compared to response in muscle strips from normal mice.   Because 
both enteric neurons and ICC express dystrophin, a decrease in contraction in response 
to EFS in muscle strip might be due to decrease in transmitter release and or altered 
function of ICC. Studies by Mule and Serio (2002) showed that the amplitude of 
spontaneous contractions in gastric muscle strips from mdx are similar to that in normal 
mice.  The spontaneous tone developed by gastric muscle was higher in mdx mice than 
that of normal mice and blockade of nNOS with L-NAME augmented contraction in 
normal mice without affecting contractions in mdx mice (Mule et al, 2006).  These 
studies suggests that impairment of nitrergic neurotransmission but not ICC or post-
junctional effector cells. Our studies provide evidence that dystrophin in smooth muscle 
plays an important role in the contractile properties of gastric smooth muscle. 
Contraction in response to the main contractile transmitter, acetylcholine, showed a 
decrease in muscle strips as well in isolated muscle cells. Studies in isolated muscle 
cells conclusively demonstrate that lack of dystrophin leads to decreased muscle 
contraction.  A limitation of our study is that we did not go beyond acetylcholine to 
assess the smooth muscle function. Although smooth muscle expresses both 
muscarinic m2 and m3 receptors, contraction in response to acetylcholine is mainly 
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mediated by activation of m3 receptors.  A decrease in contraction in response to 
acetylcholine may reflect a decrease in the expression of m3 receptors and/or changes 
in the signaling pathways activated by m3 receptors such as Gαq, phospholipase-β1 
(PLC-β1) and IP3-dependent Ca2+ release.  One approach to address this issues is to 
examine the response to other contractile agonist such as substance P which acts on 
distinct Gαq-coupled receptor or examine the response to depolarizing concentrations of 
KCl that causes Ca2+ influx to mediate contraction bypassing the GPCR activation and 
IP3-dependent Ca2+ release mechanism.  Future studies are planned to understand the 
intracellular mechanisms responsible for altered contraction to examine the role of 
dystrophin in the regulation of receptors for excitatory transmitters and the intracellular 
signaling pathways that mediate muscle contraction. Although the intracellular 
mechanisms responsible for altered muscle contraction in mdx mice have not been 
established in our study, some studies provide clues in this area.  A decrease in the 
expression of reduced type-2-ryanodine receptor expression resulting in the 
compromised sarcoplasmic reticulum Ca2+ release was attributed to a decrease in 
contraction of duodenal smooth muscle strips in mdx mice (Morel et al. 2004).  Our 
ﬁndings from studies with gastric smooth muscle of mdx mice demonstrate that the 
dystrophin plays a similar role in gut smooth muscle, as it does in vascular and airway 
smooth muscle. 
Lack of effective animal models mimicking human DMD limited our 
understanding of the pathophysiology and the development of effective therapeutic 
strategies.  The most widely used mdx model exhibits only mild phenotype compared to 
DMD patients.  A number of mouse models with more severe dystrophic phenotypes 
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have been created and these include double KO mice lacking dystrophin and utrophin, 
MyoD, α7integrin, α-dystrobrevin or glycan processing.  Except dystrophin all other 
proteins are not absent in the muscle of DMD patients and thus do not faithfully mimic 
DMD.  Later studies showed that species-specific differences in the telomere length 
account for the differences in the disease severity. The severity of DMD patients is 
postulated to be due to loss of functional muscle stem cells and the mild phenotype of 
mdx is postulated to be due to greater reserve of muscle stem cells, which is facilitated 
by longer telomeres in mice (>40 kilobases) compared to humans (~5-15 kilobases).  
Length of the telomeres determines the replicative life of cells and a reduction in 
telomere length in the muscle stem cells limits the stem cell pool and muscle repair.   
Telomerase consisting protein telomerase reverse transcriptase and telomerase RNA 
component (TERC or mTR) maintains the length of the telomeres.  Ablation of RNA 
component of telomerase results in shortened telomeres.  Mice lacking both dystrophin 
and the RNA component of teleomerase (mdx/mTR) closely approximates human DMD.  
Compared to single KO mice, the double KO mouse models exhibit exacerbated 
disease phenotypes based on various criteria such as increased serum creatine kinase 
levels, skeletal muscle fibrosis, exhaustion of mice on treadmill, kyphosis, skeletal and 
cardiac muscle myopathies and shortened life span.  The cardiomyocytes of DMD 
patients have 45% shorter telomeres compared to cardiomyocytes of normal individuals 
highlighting the importance of telomere shortening (Mourkioti et al., 2013). There is a 
14-fold greater shortening of telomeres in skeletal muscle of DMD patients compared to 
normal (Decary et al., 2000).  Similarly, tibialis anterior muscle from ~24 month old mdx 
mice have 30% shorter telomeres compared to age-matched control.   Shortening to 
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telomeres results from unlimited proliferation of degenerating muscle in DMD.  These 
findings also suggests that DMD is initiated by lack of dystrophin due to genetic defect 
and progresses into premature cardiovascular and muscle aging.  In our study we used 
both mdx and mdx/mTR mice to demonstrate the importance of dystrophin in gastric 
smooth muscle function.  Our studies also demonstrate that the changes in the mRNA 
expression of thin filament associated proteins are greater in mdx/mTR mice compared 
mdx mice.   
Several pharmacological approaches to treat DMD have been investigated.  
These include exon skipping, augmentation of cGMP pathway via inhibition of 
phosphodiesterase 5 and corticosteroids; the latter is more established and currently 
used.  Increased oxidative stress in skeletal muscle has been implicated in the 
pathogenesis of DMD.  In DMD muscle biopsies, there is 2 fold increase in protein 
carbonyl groups and isoprostanes reflecting protein damage and lipid peroxidation, 
respectively, due to reactive oxygen species.  Similar increase in protein oxidation and 
lipid peroxidation was also observed in muscle from mdx mice.    Genes involved in 
ECM remodeling and fibrosis (different types of collagen, matrix metalloproteinases, 
transforming growth factor β1) are altered both during the onset and disease 
progression.  Similarly, DNA microarray studies in mdx muscle indicate that nearly 30% 
of genes that are differentially expressed are associated with inflammation and these 
include TNFα, IL-1β, inflammatory chemokines and their receptors.  Inflammatory gene 
expression profile in mdx muscle is closely similar (~70%) to that observed in DMD 
patients (Evans et al., 2009). Administration of anti-oxidants in mdx mice was shown to 
reduce muscle damage and improve muscle function.  Treatment of mdx mice with the 
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anti-oxidant N-acetyl cysteine decreased oxidative stress and protected the muscle fiber 
from stretch-induced damage.  Studies also showed that long-term treatment of mdx 
mice with resveratrol (a naturally occurring polyphenol compound) that reduces 
oxidative stress decreased reactive oxygen species and attenuated fibrosis in skeletal 
muscle (Hori et al., 2011) (Kumo and Horio, 2016) (Terrill et al., 2013).  
Hydrogen sulfide (H2S) has been recognized as an important signaling molecule 
to mitigate oxidative stress.    The anti-oxidant effect of H2S include quenching reactive 
oxygen species (ROS) and reactive nitrogen species (RNS), modulating cellular levels 
of glutathione and thioredoxin, and activating nuclear factor (erythroid-derived 2)-like 2 
(NRF2), a key transcription factor in the expression of antioxidant enzymes.  This 
suggests that exogenous supplementation of H2S could be employed as a beneficial 
strategy to improve the injury induced by oxidative stress.   In this study we showed that 
long-term treatment of mdx/mTR mice with H2S donor SG1002 reversed the decrease in 
contractile protein expression and restored the contractile function to near normal 
levels.  SG1002 has been to shown to prevent cardiac dysfunction in mdx/mTR mice 
(Dr. Salloum’s unpublished observation).  Thus, these results demonstrate the 
significant therapeutic potential of H2S donor in dystrophin-deficient mdx/mTR mice. 
 In conclusion, our functional data using mdx and mdx/ mTR mice indicate that 
the dystrophin plays an important role in contractile properties of gastric smooth muscle 
and suggests that it is also important gastric motility in vivo. Our studies also suggest 
that with better understanding of the precise mechanism behind the role of H2S in 
reducing oxidative stress, treatment with H2S donor could be a promising therapeutic 
approach for DMD patients.   
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